Cardiac Wire #298 August 21, 2025
CSP for AV Block, Generic Entresto, and Self-Plagiarism
Cardiac Wire #297 August 18, 2025
Rivaroxaban for AFib + CAD, HF is Preventable, and PFA’s Phrenic Compilation
Cardiac Wire #296 August 14, 2025
TEER for AFMR, Recall Rampage, and Plane Noise BP
Cardiac Wire #295 August 11, 2025
TAVR in 2025, FTC vs. Edwards, and Pregablin’s HF Link
Cardiac Wire #294 August 7, 2025
Lilly Outdoes Itself, Leqvio Monotherapy, and OMRON HF Detection
Cardiac Wire #293 August 4, 2025
Pre/Post-CVD Activity, COVID vs. Flu Heart, and Aging Arteries
Cardiac Wire #292 July 31, 2025
AZ’s Anselamimab Hurdle, GDMT Improves HF, and Roche Cuts CT-173
Cardiac Wire #291 July 28, 2025
SGLT2i Uptake Disparities, Heartflow’s DECIDE, and Unethical Organ Harvesting
Cardiac Wire #290 July 24, 2025
SCCT25 Top Trends, MI Mix-Ups, and EchoNext
Cardiac Wire #289 July 21, 2025
Polypills’ CVD Potential, Renal Denervation Coverage, and Women’s Hypertension
Cardiac Wire #288 July 17, 2025
Kerendia comes to HF, PREVENT underperforms, and Women’s Hypertension
Cardiac Wire #287 July 14, 2025
CV Deaths are Changing, SAVR Stagnation, and Elderly ACS
Cardiac Wire #286 July 10, 2025
H1’s Top 6 Cardiology Trends and More
Cardiac Wire #285 July 3, 2025
Kardium’s PFA Funds, the BABICORN, and the Work Diet
Cardiac Wire #284 June 30, 2025
A Polymer Mitral Valve Success and More From NYV 2025
Cardiac Wire #283 June 26, 2025
Microplastics Impact CVD, J&J Injunction, and Novo Quits H&H
Cardiac Wire #282 June 23, 2025
Edwards’ Evoque ADEs, Philips’ Angio Recall, and Baby BP
Cardiac Wire #281 June 19, 2025
Lilly Buys Verve, Cold-Triggered AFib, and GLUCOSE
Cardiac Wire #280 June 16, 2025
